Famotidine Dosing for 4-Month-Old Infant (6.94 kg)
For a 4-month-old infant weighing 6.94 kg, the recommended famotidine dose is 0.5 mg/kg twice daily (approximately 3.5 mg twice daily), which can be administered using the oral suspension formulation.
Dosing Rationale
The FDA-approved famotidine tablets (20 mg and 40 mg) are not appropriate for this infant because these strengths far exceed the recommended pediatric dose for patients weighing less than 40 kg 1. You must use an alternative formulation—specifically, the oral suspension.
Weight-Based Calculation
For infants and young children, the established pediatric dose is:
- 1 mg/kg/day divided into 2 doses for treatment of GERD and peptic ulcer disease 2
- For this 6.94 kg infant: 0.5 mg/kg per dose twice daily = 3.47 mg per dose
This dosing is supported by both the AAP gastroesophageal reflux guidelines 2 and clinical research demonstrating safety and efficacy in infants 3.
Formulation and Administration
Famotidine oral suspension (cherry-banana-mint flavored) is the appropriate formulation, providing 40 mg/5 mL concentration 2.
- Dose volume: Approximately 0.43 mL per dose (3.5 mg), administered twice daily
- Can be given with or without food
- Administer doses approximately 12 hours apart
Evidence Supporting This Dose
The 0.5 mg/kg dose has demonstrated:
- Significant improvement in regurgitation frequency in infants 1.3-10.5 months of age 3
- Effective gastric acid suppression with pH elevation to >4.0 4
- Good safety profile with minimal adverse effects 3, 5
Safety Considerations
Common but generally mild adverse effects in infants include 3:
- Agitation or irritability (including head-rubbing behavior)
- Somnolence
- Anorexia
Important caveat: Some infants may require dose individualization. While 0.5 mg/kg is effective for most infants, research suggests that 1.0 mg/kg may be more efficacious in select cases with inadequate response 3. However, start with the lower dose and titrate only if clinically indicated.
Renal Function Consideration
Assuming normal renal function in this infant, no dose adjustment is needed 1. However, if moderate or severe renal impairment is present, dosage reduction would be necessary as famotidine is substantially excreted by the kidney 1.
Duration of Therapy
For symptomatic non-erosive GERD, treatment duration is typically up to 6 weeks 2, 1. For erosive esophagitis, treatment may extend up to 12 weeks 2, 1. Reassess clinical response and need for continued therapy at appropriate intervals.